DISORDERS OF PRIMARY HEMOSTASIS Flashcards

1
Q

Characterized by hyperextensible skin, hypermobile joints, joint laxity, fragile tissues, subcutaneous hematomas

A

Ehlers-Danlos Syndrome (Cutis Hyperelastica)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Inheritance pattern of Ehlers-Danlos

A

Autosomal dominant inheritance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Most common in children, caused by immunologic damage to endothelial cells, marked by gastrointestinal bleeding and joint swelling

A

Henoch-Schonlein Purpura (Allergic Purpura, Nonthrombocytopenic Purpura)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Caused by a deficiency in ascorbic acid, leading to impaired collagen and hyaluronic acid synthesis

A

Scurvy (Vitamin C Deficiency)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Normal results in vascular disorder

A

Platelet count, platelet function, coagulation test

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Abnormal results in vascular disorder

A

Bleeding time, Rumple-Leede test

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Most common inherited vascular bleeding disorder characterized by localized dilation of capillary walls (skin and mucous membranes)

A

Hereditary Hemorrhagic Telangiectasia (Rendu-Osler-Weber Syndrome)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Quantitative platelet disorder: Impaired or Decreased Platelet Production

A

Thrombocytopenia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Thrombocytopenia increased platelet destruction conditions

A

HUS, DIC, ITP, TTP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

HIT mechanism

A

Platelets activated by heparin-IgG antibodies against Heparin-PF4 complex

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Thrombocytopenia conditions with impaired or decreased platelet production

A

Bernard-Soulier syndrome, Fanconi anemia, TAR syndrome, Viral infections, Leukemia, Megaloblastic anemias, Wiskott-Aldrich syndrome, MYH9 gene mutations (e.g., May-Hegglin Anomaly)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Thrombocytopenia conditions with increased splenic sequestration

A

Gaucher disease, Hodgkin’s disease, Sarcoidosis, Lymphoma, Cirrhosis of the liver, Portal hypertension

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Thrombocytosis: increased platelet count groups

A

Reactive Thrombocytosis (secondary thrombocytosis), Autonomous Thrombocytosis (Primary thrombocytosis)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Reactive Thrombocytosis characteristics

A

Moderately increased platelet count

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Reactive thrombocytosis is associated with

A

Recovery from splenectomy, acute blood loss, major surgery

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Autonomous Thrombocytosis characteristics

A

Markedly increased platelet count

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Conditions associated with Autonomous Thrombocytosis

A

Myeloproliferative neoplasms (e.g., Essential thrombocythemia, CML, Polycythemia vera, PMF)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Clonal proliferation of bone marrow stem cells with elevated myeloid cells

A

Myeloproliferative Neoplasms (MPNs)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Uncontrolled megakaryocyte proliferation, platelet count > 1 million/µL

A

Essential Thrombocythemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Condition with platelet adhesion disorder due to deficiency of Gp Ib/V/IX

A

Bernard Soulier Syndrome (BSS)

21
Q

Inheritance pattern of Bernard Soulier Syndrome (BSS)

A

Autosomal recessive

22
Q

Characteristic platelet appearance in Bernard Soulier Syndrome (BSS)

A

Giant platelets

23
Q

Aggregation result in Bernard Soulier Syndrome (BSS) with ristocetin

A

Normal aggregation

24
Q

Most common congenital bleeding disorder

A

von Willebrand’s Disease (vWD)

25
Deficiency in von Willebrand’s Disease (vWD)
vWF (von Willebrand factor)
26
Inheritance pattern of von Willebrand’s Disease (vWD)
Autosomal dominant
27
Most common type of von Willebrand’s Disease (vWD)
Type I vWD
28
Factor VIII level in von Willebrand’s Disease (vWD)
Decreased factor VIII
29
PT and APTT results in von Willebrand’s Disease (vWD)
Normal PT, prolonged APTT
30
Platelet aggregation results in von Willebrand’s Disease (vWD)
Normal aggregation with ADP, Collagen, Epinephrine/Adrenaline; abnormal with ristocetin
31
Primary platelet surface receptor for vWF in platelet adhesion
GP Ib/IX/V
32
Most common and mildest form of von Willebrand’s Disease (vWD)
Type I vWD
33
Bleeding time and bleeding tendency in Type I von Willebrand’s Disease (vWD)
Normal or increased bleeding time; mild bleeding tendency
34
Petechiae in Type I von Willebrand’s Disease (vWD)
None
35
Bleeding time in Type II von Willebrand’s Disease (vWD)
Increased bleeding time
36
Bleeding tendency in Type II von Willebrand’s Disease (vWD)
Moderate bleeding tendency
37
Petechiae in Type II von Willebrand’s Disease (vWD)
Usually none
38
Rarest and most severe form of von Willebrand’s Disease (vWD)
Type III vWD
39
Bleeding time and bleeding tendency in Type III von Willebrand’s Disease (vWD)
Increased bleeding time; often severe bleeding tendency
40
Petechiae in Type III von Willebrand’s Disease (vWD)
Occasionally present
41
Platelet aggregation disorder with GP IIb/IIIa deficiency
Glanzmann’s thrombasthenia
42
Inheritance of Glanzmann’s thrombasthenia
Autosomal recessive (AR)
43
Bleeding time in Glanzmann’s thrombasthenia
Very prolonged bleeding time
44
Platelet aggregation response in Glanzmann’s thrombasthenia with ACE
Abnormal aggregation
45
Platelet aggregation response in Glanzmann’s thrombasthenia with ristocetin
Normal response
46
Condition with absence of fibrinogen affecting platelet aggregation
Hereditary afibrinogenemia
47
Key receptor for platelet aggregation involving fibrinogen
GP IIb/IIIa
48
Process where platelets adhere to other platelets
Platelet aggregation
49
Disorder with thromboxane pathway involvement
Thromboxane pathway disorders